Sowell Financial Services LLC Axsome Therapeutics, Inc. Transaction History

Sowell Financial Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$50.63 - $73.5 $18,631 - $27,048	-368 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$55.91 - $81.44 $670 - $977	12 Added 3.37%	368 $21,000
Q4 2020 Jan 13, 2021	SELL	$66.31 - $86.52 $1,259 - $1,643	-19 Reduced 5.07%	356 $29,000
Q3 2020 Nov 12, 2020	SELL	$68.34 - $85.84 $3,143 - $3,948	-46 Reduced 10.93%	375 $27,000
Q2 2020 Aug 13, 2020	SELL	$49.87 - $98.69 $21,095 - $41,745	-423 Reduced 50.12%	421 $35,000
Q1 2020 May 12, 2020	SELL	$41.2 - $101.31 $33,166 - $81,554	-805 Reduced 48.82%	844 $50,000
Q4 2019 Feb 07, 2020	BUY	$16.71 - $106.24 $15,189 - $96,572	909 Added 122.84%	1,649 $170,000
Q3 2019 Nov 14, 2019	BUY	$20.24 - $29.16 $14,977 - $21,578	740 New	740 $15,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.43B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.